Yes. Jiangsu Hengrui Pharmaceuticals (600276.SS) passes the AAOIFI Shari’ah Standard 21 screen.
Yes. Jiangsu Hengrui Pharmaceuticals (600276.SS) passes the Catholic screen based on the USCCB investment guidelines.
Yes. Jiangsu Hengrui Pharmaceuticals (600276.SS) passes the Biblically Responsible Investing (BRI) screen.